In a recent IQVIA webinar, ‘Partnering with the NHS in a crisis’, representative experts from the life sciences industry and the NHS explored why collaboration between the two is more criti
Joint working has become something of the norm in the last decade, but have we taken the time to step back, take stock and see if we are doing it right?
Japan’s Taisho Pharmaceutical looks like it could be heading into private ownership, thanks to a management buyout offer (MBO) that could value the company at almost $5 bi
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio